Dopamine receptor whose exercise is mediated by G proteins which inhibit adenylyl cyclase (PubMed:21645528). Positively regulates postnatal regression of retinal hyaloid vessels by using suppression of VEGFR2/KDR activity, downstream of OPN5 (By similarity). FDA believes this to be one of the most exact process for determining the contents of OTC